Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19
Henrik Berg Rasmussen, Gesche Jürgens, Ragnar Thomsen, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 14

Showing 14 citing articles:

Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
Zhonglei Wang, Liyan Yang, Xian-qing Song
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Antiviral drug recognition and elevator-type transport motions of CNT3
Nicholas J. Wright, Feng Zhang, Yang Suo, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1144-1153
Closed Access | Times Cited: 3
Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment
Amy Q. Wang, Natalie R. Hagen, Elias Carvalho Padilha, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model
Woojin Jeon, Hong-Ki Lee, Young‐Guk Na, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1561-1575
Open Access | Times Cited: 8
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19
Henrik Berg Rasmussen, Ragnar Thomsen, Peter Riis Hansen
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 14
Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment
Amita Verma, Pradeep Kumar, Irine Pauly, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3677-3705
Closed Access | Times Cited: 9
Scoping insight on antiviral drugs against COVID-19
Ahmed S. Ali, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 10, pp. 103385-103385
Open Access | Times Cited: 9
Important roles of transporters in the pharmacokinetics of anti-viral nucleoside/nucleotide analogs
Mengbi Yang, Xin Xu
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 7-8, pp. 483-505
Open Access | Times Cited: 6
Exploration of the optimal GS-441524 trough concentration for treating COVID-19
Yuki Nakano, Yoko Inokuchi, Tadashi Hayama, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 2, pp. 106892-106892
Open Access | Times Cited: 3
The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?
Leandro S. M. Miranda
Archiv der Pharmazie (2022) Vol. 356, Iss. 1
Closed Access | Times Cited: 5
Chain Termination Effects of Chemically Modified Nucleoside Analogs on SARS-CoV-2 RNA Polymerase
Lin Yang, Xinzhou Xu, Zhibin Liang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Preclinical Pharmacokinetics andIn VitroProperties of GS-441524, A Potential Oral Drug Candidate for COVID-19 Treatment
Amy Q. Wang, Natalie R. Hagen, Elias Carvalho Padilha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography
Chen Sun, Бо Лю, Fengzhi Zhou, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5634-5634
Open Access
Page 1

Scroll to top